2024-11-09 - Analysis Report
## Danaher Corp (DHR) Stock Analysis Report

This report analyzes Danaher Corp (DHR), a leading global manufacturer and distributor of scientific, medical, and industrial products, based on provided data. 

**1. Performance vs. S&P 500:**

DHR has significantly outperformed the S&P 500 (VOO) with a cumulative return of 214.9% compared to VOO's 141.71%. The difference in return is 73.19%, which places DHR at the 33.9th percentile of its historical performance range. 

**Alpha & Beta Analysis:**

The table showcases consistent positive alpha values, indicating DHR's ability to outperform the market over various timeframes. The beta values, generally around 0.8-1.0, suggest that DHR's price tends to move with the market but with slightly less volatility.

**2. Recent Price Movement:**

- **Closing Price:** $246.1
- **Last Market:** $246.77
- **5-Day Moving Average:** $247.77 
- **20-Day Moving Average:** $256.27
- **60-Day Moving Average:** $265.97

The price is currently below all three moving averages, indicating a short-term downtrend.

**3. Technical Indicators:**

- **RSI (Relative Strength Index):** 18.54 - This indicates the stock is currently oversold.
- **PPO (Percentage Price Oscillator):** -0.15 - This indicates a negative trend, although the value is close to zero, suggesting the trend may be weakening.
- **Delta_Previous_Relative_Divergence:** -14.55 - This negative value suggests a short-term downtrend, possibly driven by recent market volatility. 
- **Expected Return:** 82.93% - This represents the expected long-term (2+ years) return relative to S&P 500.

**4. Recent Earnings and Outlook:**

| Date      | EPS   | Revenue   |
|-----------|-------|-----------|
| 2024-10-22 | 1.13  | 5.80 B$  |
| 2024-07-23 | 1.23  | 5.74 B$  |
| 2024-04-23 | 1.47  | 5.80 B$  |
| 2024-02-21 | 1.46  | 6.41 B$  |
| 2023-10-24 | 1.53  | 5.62 B$  |

The most recent earnings announcement was on 2024-10-22. The company's EPS of 1.13 beat analyst expectations, while revenue of 5.80 B$ was slightly below expectations. 

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|-----------|-----------|---------------|
| 2024-09-30  | $5.80B  | 58.66%        |
| 2024-06-30  | $5.74B  | 59.69%        |
| 2024-03-31  | $5.80B  | 60.16%        |
| 2023-12-31  | $2.69B  | 60.27%        |
| 2023-09-30  | $5.62B  | 58.23%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE |
|-----------|-----------|-----|
| 2024-09-30  | $51.30B  | 1.59% |
| 2024-06-30  | $49.90B  | 1.82% |
| 2024-03-31  | $53.44B  | 2.04% |
| 2023-12-31  | $53.49B  | 2.02% |
| 2023-09-30  | $52.41B  | 2.15% |

DHR demonstrates strong revenue growth and consistently high profit margins. Equity and ROE values also show healthy financial standing.

**6. News and Recent Issues:**

**Recent Market Outlook:**

DHR has been impacted by general market volatility, but its strong fundamentals and long-term growth prospects continue to attract investors. 

**Analyst Opinions and Performance Highlights:**

*  **FINBOLD:** Analyst ratings on FINBOLD show a positive outlook for DHR, with several analysts suggesting a "buy" recommendation.
* **Shacnews:** Recent earnings reports on Shacknews highlighted the company's strong performance and positive outlook for the future, which aligns with the company's financial information.

**7. Overall Analysis:**

DHR demonstrates a strong track record of outperforming the market, supported by consistent profitability and healthy financials. The recent price dip might offer a buying opportunity for long-term investors, especially considering the positive expected return. 

**However, it's crucial to:**

* Monitor the impact of market volatility on the stock's performance.
* Stay informed about any new regulatory or industry changes that might influence the company's future prospects.
* Consider diversification and investment goals before making any investment decisions.

**Conclusion:**

DHR presents a compelling investment opportunity with its proven track record and promising long-term outlook. However, investors should remain cautious and actively monitor its performance in the current market environment.
